A new trading day began on Tuesday, with IO Biotech Inc (NASDAQ: IOBT) stock price up 2.29% from the previous day of trading, before settling in for the closing price of $0.89. IOBT’s price has ranged from $0.66 to $2.10 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 31.62%. With a float of $44.87 million, this company’s outstanding shares have now reached $65.88 million.
In an organization with 68 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 43.6%, operating margin of -8686.22%, and the pretax margin is -8017.03%.
IO Biotech Inc (IOBT) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of IO Biotech Inc is 31.89%, while institutional ownership is 41.67%. The most recent insider transaction that took place on Dec 23 ’24, was worth 10,120. In this transaction Chief Executive Officer of this company bought 12,500 shares at a rate of $0.81, taking the stock ownership to the 49,891 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Financial Officer bought 10,250 for $0.83, making the entire transaction worth $8,483. This insider now owns 84,632 shares in total.
IO Biotech Inc (IOBT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 31.62% per share during the next fiscal year.
IO Biotech Inc (NASDAQ: IOBT) Trading Performance Indicators
Here are IO Biotech Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.37, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.25 in one year’s time.
Technical Analysis of IO Biotech Inc (IOBT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.28 million. That was better than the volume of 0.26 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 72.18%. Additionally, its Average True Range was 0.08.
During the past 100 days, IO Biotech Inc’s (IOBT) raw stochastic average was set at 24.75%, which indicates a significant decrease from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.82% in the past 14 days, which was lower than the 131.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9804, while its 200-day Moving Average is $1.2519. However, in the short run, IO Biotech Inc’s stock first resistance to watch stands at $0.9283. Second resistance stands at $0.9467. The third major resistance level sits at $0.9833. If the price goes on to break the first support level at $0.8733, it is likely to go to the next support level at $0.8367. Assuming the price breaks the second support level, the third support level stands at $0.8183.
IO Biotech Inc (NASDAQ: IOBT) Key Stats
With a market capitalization of 59.95 million, the company has a total of 65,881K Shares Outstanding. Currently, annual sales are 0 K while annual income is -86,080 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,020 K.
